More than 250,000 dementia patients in England could miss new treatments
More than 250,000 dementia patients could miss out on new treatments for the disease because they do not have a formal diagnosis, according to government figures.
NHS data published for the first time shows the prevalence of different types of dementia with which people in England have been diagnosed.
Dementia is an umbrella term for many different conditions, affecting more than 55 million people worldwide.
This week, health regulators were urged to approve two new game-changing dementia drugs, after a landmark study confirmed that donanemab slowed cognitive decline in Alzheimer’s patients by 35%, while last year, a second drug, lecanemab, was found to reduce the rate by 27%.
The NHS primary care dementia figures estimate that there are about 708,000 people over 65 with dementia in England, but only about 450,000 have a recorded diagnosis. That means that more than 250,000 are missing out on these potential new treatments.
Source: The Guardian, 20 July 2023